GENEVA, March 3 -- VAXCELL-BIO CO., LTD. (12-55 Sandan-gil, Hwasun-eupHwasun-gunJeollanam-do 58141), 주식회사 박셀바이오 (전라남도화순군화순읍 산단길 12-55) filed a patent application (PCT/KR2024/012554) for "COMPOSITION FOR TREATING CANCER IN TUMOR-AFFECTED DOGS COMPRISING RECOMBINANT CANINE INTERLEUKIN-15" on Aug 22, 2024. With publication no. WO/2026/042913, the details related to the patent application was published on Feb 26, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO...